News | Artificial Intelligence
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting 2019, held May 31 – June 4 in Chicago. The accepted abstract highlights the feasibility of AI-based biomarkers in metastatic non-small cell lung cancer, based on the H&E analysis that predicts response to immune checkpoint inhibitors (ICI).
May 31, 2019 
News | Artificial Intelligence
May 31, 2019 — Intelerad Medical Systems announced a $75 million investment in research and development (R&D) to expand ...
May 31, 2019 
Blog | Information Technology
It is not surprising that pressure is mounting for medical providers to improve the care outcomes of their patients ...
May 31, 2019 Sponsored Content
Sponsored Content
Videos | Radiology Business
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
November 11, 2025 
Feature | Mammography | By Olive Peart M.S., R.T.(R)(M)
In recent years there has been a lot of debate about the role of the mammographer with regard to examining the patient’s ...
May 31, 2019 
Feature | Cardiac Imaging | By Greg Freiherr
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the annual ...
May 31, 2019 
Feature | Radiology Business | By Arjen Radder
Change is a consistent theme in our world today, no matter where you look. In healthcare, change — while slower than ...
May 31, 2019 Sponsored Content
Feature | Breast Imaging
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
October 24, 2025 
Feature | Computed Tomography (CT) | By Jeff Zagoudis
As of 2015, approximately 79 million computed tomography (CT) scans were performed each year in the U.S. Of those, 36 ...
May 30, 2019 
Sponsored Content | Case Study | Enterprise Imaging
In this study, the client was a large enterprise health system serving 1.4 million patients across the United States ...
May 30, 2019 
Feature | Artificial Intelligence | By Greg Freiherr
Much has been made in recent years about the explosion of artificial intelligence (AI) in radiology and how it might ...
May 30, 2019 Sponsored Content
Sponsored Content
Videos | Radiology Business
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
October 09, 2025 
Feature | Electronic Medical Records (EMR) | By Larry Sitka and Jef Williams
Medical imaging and informatics are critical to delivering care and managing wellness. Imaging was an early adopter of ...
May 30, 2019 
Case Study | Information Technology
Cleveland Clinic Union Hospital (CCUH) has served the community of Ohio’s Tuscarawas Valley for more than 100 years ...
May 30, 2019 
Feature | Radiation Oncology | By Jeff Zagoudis
Computed tomography (CT) has traditionally played an important role in the development of radiation therapy treatment ...
May 29, 2019 Sponsored Content
Case Study | PACS
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
February 03, 2025 
Blog | Radiology Business
Imaging Technology News (ITN) recently took home top honors for best technical content for its team coverage of the ...
May 29, 2019 
News | Ultrasound Imaging
May 29, 2019 — QT Ultrasound recently showcased its advanced ultrasound technology at the Acoustical Society of America ...
May 29, 2019 
News | Digital Radiography (DR)
A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described the use of Konica Minolta’s Dynamic Digital Radiography (DDR) technology in the assessment of undifferentiated dyspnea.
May 29, 2019 
News | Lung Imaging
Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016 despite screening recommendations, according to a new analysis. These numbers come despite U.S. Preventive Services Task Force (USPSTF) and American Society of Clinical Oncology (ASCO) screening recommendations.
May 29, 2019 
Technology | Digital Pathology
Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the U.S.
May 29, 2019 
Feature | Radiation Therapy | By Jeff Zagoudis
While radiation therapy as a discipline is well into maturity, new technology advances continue to drive the field ...
May 29, 2019 
Sponsored Content | Case Study | Radiation Therapy
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at ...
May 29, 2019 
News | Oncology Diagnostics
A new clinical study shows that Natera's Signatera test identified colorectal cancer recurrence up to 16.5 months earlier than radiologic imaging by detecting traces of tumor DNA in the blood after surgery. The test also identified patients most likely to relapse, both before and after chemotherapy.1 Results were published in the May issue of JAMA Oncology.
May 28, 2019 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now